Published in Lancet on July 03, 2009
Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci U S A (2010) 1.71
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol (2011) 1.07
Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes. Br J Clin Pharmacol (2010) 0.98
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. World J Gastroenterol (2013) 0.97
Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol (2013) 0.89
Mortality following acute medical admission in Denmark: a feasibility study. Clin Epidemiol (2010) 0.86
Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy. World J Gastroenterol (2010) 0.86
Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J Gastroenterol (2015) 0.85
Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention. Heart Vessels (2012) 0.85
Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. J Gastroenterol (2012) 0.84
Managing adverse effects and drug-drug interactions of antiplatelet agents. Nat Rev Cardiol (2011) 0.84
Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: the OITA-GF study 2. BMC Res Notes (2013) 0.81
Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries. J Gastroenterol (2013) 0.81
Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. Ther Adv Chronic Dis (2013) 0.80
DUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug. Ther Adv Musculoskelet Dis (2012) 0.80
State-of-the-art management of acute bleeding peptic ulcer disease. Saudi J Gastroenterol (2013) 0.79
Clinical evidence of interaction between clopidogrel and proton pump inhibitors. World J Cardiol (2011) 0.79
PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis. PLoS One (2015) 0.79
Mast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam. PLoS One (2011) 0.78
Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers. BMC Res Notes (2013) 0.78
Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol (2016) 0.78
Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users. Gastroenterol Res Pract (2015) 0.77
The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance? Clin Pharmacol (2010) 0.77
Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury. United European Gastroenterol J (2013) 0.76
Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective. J Gastroenterol (2015) 0.76
25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut Liver (2016) 0.76
Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin. Drug Healthc Patient Saf (2010) 0.75
NSAIDs and aspirin: notorious or FAMOUS? Lancet (2009) 0.75
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Relat Outcome Meas (2010) 0.75
Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review. J Pharm Health Care Sci (2016) 0.75
Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial. Am J Gastroenterol (2016) 0.75
Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study. Clin Endosc (2016) 0.75
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury. J Clin Biochem Nutr (2016) 0.75
Histamine H2 receptor antagonists for decreasing gastrointestinal harms in adults using acetylsalicylic acid: systematic review and meta-analysis. Open Med (2012) 0.75
Does rebamipide prevent gastric mucosal injury in patients taking aspirin and clopidogrel? Dig Dis Sci (2014) 0.75
Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis. Medicine (Baltimore) (2014) 0.75
Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study. Biomed Res Int (2014) 0.75
Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. Eur J Heart Fail (2012) 2.72
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology (2013) 1.81
25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis (2012) 1.46
Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation (2009) 1.36
Exposure of infants to outdoor and indoor air pollution in low-income urban areas - a case study of Delhi. J Expo Anal Environ Epidemiol (2003) 1.20
Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study. BMJ (2009) 1.17
Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med (2009) 1.08
Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study. BMC Public Health (2008) 0.97
Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health (2011) 0.92
Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail (2009) 0.91
Distribution of lymph nodes in the neck in cases of tuberculous cervical lymphadenitis. Acta Otolaryngol (2004) 0.90
Prevalence of hearing loss and ear morbidity among adolescents and young adults in rural southern Nepal. Int J Audiol (2010) 0.88
Frequency and effective treatment of ulcers and sinuses in cases of tuberculous cervical lymphadenitis. J Coll Physicians Surg Pak (2005) 0.85
Outcome of surgical management of laryngeal carcinoma: a 5-year experience. Acta Otolaryngol (2004) 0.79